Akkermansia muciniphila strain and use thereof
AssigneeKobiolabs, Inc.
InventorsGwang Pyo Ko, Hyo Shin Yoon, Chung Hwan Cho, Hyun Ju You, Tae Wook Nam
Life of this patent
Estimating the term…
Loading patent…
AssigneeKobiolabs, Inc.
InventorsGwang Pyo Ko, Hyo Shin Yoon, Chung Hwan Cho, Hyun Ju You, Tae Wook Nam
Estimating the term…
The present invention relates to Akkermansia muciniphila SNUG-61027 strain (accession number KCTC 13530BP) and use thereof, specifically, a composition for suppressing appetite or preventing, ameliorating, alleviating or treating metabolic diseases, comprising the strain, or a culture solution thereof, etc. or a B2UM07 protein isolated therefrom as an active ingredient, and use thereof for suppressing appetite or preventing, ameliorating, alleviating or treating metabolic diseases, and a method of suppressing appetite or preventing, ameliorating, alleviating or treating metabolic diseases using the same are provided. Through this, among the anti-obesity effects, not only weight reduction and glucose homeostasis regulation, but also the effect on brown fat and the effect of secreting appetite regulating hormones are exhibited.
A method of suppressing appetite or treating metabolic diseases associated with glucagon-like peptide-1 (GLP-1), comprising administering a composition comprising Akkermansia muciniphila SNUG-61027 strain with accession number KCTC 13530BP to a subject in need thereof.
Dependencies are inferred from the claim text.